Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Journal of Cancer

Showing results (561-570 of 5,561) with videos related to

Pageof 557
Sort By:
Journal of Cancer|November 21, 2017
Combination of plasma HA and circulating M2-like monocytes may serve as a diagnostic marker for breast cancerBoke Zhang, Manlin Cao, Yiqing He, et al.
Journal of Cancer|November 21, 2017
Total mesopancreas excision for the treatment of pancreatic head cancerJingyong Xu, Xiaodong Tian, Yiran Chen, et al.
Journal of Cancer|November 21, 2017
Clinicopathological Characteristics and Prognosis of Ossifying Fibroma in the Jaws of Children: A Retrospective StudyYing Liu, Xiao-Feng Shan, Xue-Sheng Guo, et al.
Journal of Cancer|November 21, 2017
Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-AnalysisQingcai Meng, Si Shi, Chen Liang, et al.
Journal of Cancer|November 21, 2017
High Intratumoral Expression of Tetranectin Associates with Poor Prognosis of Patients with Gastric Cancer after GastrectomyHao Chen, Haojie Li, Junjie Zhao, et al.
Journal of Cancer|November 21, 2017
A Phase II Randomized Controlled Trial: Definitive Concurrent Chemoradiotherapy with Docetaxel Plus Cisplatin versus 5-Fluorouracil plus Cisplatin in Patients with Oesophageal Squamous Cell CarcinomaYujia Zhu, Wenwen Zhang, Qiaoqiao Li, et al.
Journal of Cancer|November 21, 2017
Pancreatic Cancer in Lynch Syndrome PatientsLuis Bujanda, Marta Herreros-Villanueva
Journal of Cancer|November 21, 2017
Continuation of Tyrosine Kinase Inhibitor is Associated with Survival Benefit in NSCLC Patients with Exon 19 Deletion after Solitary ProgressionFeifei Na, Jie Zhang, Lei Deng, et al.
Journal of Cancer|November 21, 2017
R.E.N.A.L. Nephrometry Score: A Preoperative Risk Factor Predicting the Fuhrman Grade of Clear-Cell Renal CarcinomaShao-Hao Chen, Yu-Peng Wu, Xiao-Dong Li, et al.
Journal of Cancer|November 21, 2017
Polymorphisms of <i>CCNB1</i> Associated With the Clinical Outcomes of Platinum-Based Chemotherapy in Chinese NSCLC PatientsDi Liu, Wen Xu, Xi Ding, et al.
Pageof 557

Showing results (561-570 of 5,561) with videos related to

Sort By:
Pageof 557
Journal of Cancer|November 21, 2017
Combination of plasma HA and circulating M2-like monocytes may serve as a diagnostic marker for breast cancerBoke Zhang, Manlin Cao, Yiqing He, et al.
Journal of Cancer|November 21, 2017
Total mesopancreas excision for the treatment of pancreatic head cancerJingyong Xu, Xiaodong Tian, Yiran Chen, et al.
Journal of Cancer|November 21, 2017
Clinicopathological Characteristics and Prognosis of Ossifying Fibroma in the Jaws of Children: A Retrospective StudyYing Liu, Xiao-Feng Shan, Xue-Sheng Guo, et al.
Journal of Cancer|November 21, 2017
Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-AnalysisQingcai Meng, Si Shi, Chen Liang, et al.
Journal of Cancer|November 21, 2017
High Intratumoral Expression of Tetranectin Associates with Poor Prognosis of Patients with Gastric Cancer after GastrectomyHao Chen, Haojie Li, Junjie Zhao, et al.
Journal of Cancer|November 21, 2017
A Phase II Randomized Controlled Trial: Definitive Concurrent Chemoradiotherapy with Docetaxel Plus Cisplatin versus 5-Fluorouracil plus Cisplatin in Patients with Oesophageal Squamous Cell CarcinomaYujia Zhu, Wenwen Zhang, Qiaoqiao Li, et al.
Journal of Cancer|November 21, 2017
Pancreatic Cancer in Lynch Syndrome PatientsLuis Bujanda, Marta Herreros-Villanueva
Journal of Cancer|November 21, 2017
Continuation of Tyrosine Kinase Inhibitor is Associated with Survival Benefit in NSCLC Patients with Exon 19 Deletion after Solitary ProgressionFeifei Na, Jie Zhang, Lei Deng, et al.
Journal of Cancer|November 21, 2017
R.E.N.A.L. Nephrometry Score: A Preoperative Risk Factor Predicting the Fuhrman Grade of Clear-Cell Renal CarcinomaShao-Hao Chen, Yu-Peng Wu, Xiao-Dong Li, et al.
Journal of Cancer|November 21, 2017
Polymorphisms of <i>CCNB1</i> Associated With the Clinical Outcomes of Platinum-Based Chemotherapy in Chinese NSCLC PatientsDi Liu, Wen Xu, Xi Ding, et al.
Pageof 557